Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients von Nguyen, Q D, Schachar, R A, Nduaka, C I, Sperling, M, Basile, A S, Klamerus, K J, Chi-Burris, K, Yan, E, Paggiarino, D A, Rosenblatt, I, Khan, A, Aitchison, R, Erlich, S S

Volltext

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial von Epstein, J B, Silverman, Jr, S, Paggiarino, D A, Crockett, S, Schubert, M M, Senzer, N N, Lockhart, P B, Gallagher, M J, Peterson, D E, Leveque, F G

Volltext

A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsma... von Scarantino, Charles W., McCunniff, Ann J., Evans, Greg, Young, Charles W., Paggiarino, Dario A.

Volltext

Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5 % phenylephrine von HOGAN, T. S, MCDANIEL, D. D, BARTLETT, J. D, HART, K. K, PAGGIARINO, D. A

Volltext

Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study) von Nguyen, Quan Dong, MD, MSc, Schachar, Ronald A., MD, PhD, Nduaka, Chudy I., DVM, PhD, Sperling, Marvin, MD, Klamerus, Karen J., PharmD, Chi-Burris, Katherine, MPH, Yan, Eric, PhD, Paggiarino, Dario A., MD, Rosenblatt, Irit, MD, Aitchison, Roger, MS, Erlich, Shai S., PhD

Volltext

A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma von Pal, Sumanta K., Drabkin, Harry A., Reeves, James A., Hainsworth, John D., Hazel, Susan E., Paggiarino, Dario A., Wojciak, Jon, Woodnutt, Gary, Bhatt, Rupal S.

Volltext

First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery von Bacharach, Jason, McCabe, Cathleen, Jackson, Mitchell, Rao, Sanjay, Singh, I Paul, Heersink, Sebastian, Radcliffe, Nathan, Weinstock, Robert, Paggiarino, Dario, Patel, Keyur

Volltext

A multicenter, open-label, single-arm, phase 2 study of the S1P inhibitor sonepcizumab (LT1009) in patients with previously treated metastatic renal cell carcinoma (mRCC) von Bhatt, Rupal Satish, Pal, Sumanta Kumar, Drabkin, Harry A., Hainsworth, John D., Dorr, Andrew, Atkins, Michael B., Mier, James Walter, Wang, Xiaoen, Sabbadini, Roger Allen, Paggiarino, Dario

Volltext

A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension von Goldberg, I, Li, X-Y, Selaru, P, Paggiarino, D

Volltext